These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1705424

  • 1. Physico-chemical properties of the new antibronchospastic agent isbufylline.
    Agostini O, Bonacchi G, Dapporto P, Paoli P, Fedi M, Manzini S.
    Arzneimittelforschung; 1990 Oct; 40(10):1089-92. PubMed ID: 1705424
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and analytical profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
    Agostini O, Bonacchi G, Coppini G, Di Marco G, Paoli P, Toja E.
    Arzneimittelforschung; 1995 Jun; 45(6):684-8. PubMed ID: 7646571
    [Abstract] [Full Text] [Related]

  • 3. Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride.
    Guechot C, Bertrand A, Cramaille P, Teulon JM.
    Arzneimittelforschung; 1988 May; 38(5):655-60. PubMed ID: 2901263
    [Abstract] [Full Text] [Related]

  • 4. Physico-chemical properties and stabilities of the highly potent calcium antagonist benidipine hydrochloride.
    Suzuki H, Ono E, Ueno H, Takemoto Y, Nakamizo N.
    Arzneimittelforschung; 1988 Nov; 38(11A):1671-6. PubMed ID: 3219139
    [Abstract] [Full Text] [Related]

  • 5. Physico-chemical properties and stability of cilostazol.
    Shimizu T, Osumi T, Niimi K, Nakagawa K.
    Arzneimittelforschung; 1985 Nov; 35(7A):1117-23. PubMed ID: 4074422
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions.
    Manzini S, Meini S, Giachetti A, Beani L, Borea PA, Antonelli T, Ballati L, Bacciarelli C.
    Arzneimittelforschung; 1990 Nov; 40(11):1205-13. PubMed ID: 1707621
    [Abstract] [Full Text] [Related]

  • 7. Physico-chemical properties and stability of the new hypoxia-selective agent 7-chloro-3-[[N,N-dimethylamino)propyl]amino]-2-quinoxalinecarbonitrile 1,4-di-N-oxide hydrochloride.
    Zamalloa E, Aldana I, Bachiller CM, Monge A.
    Arzneimittelforschung; 1997 Jul; 47(7):873-8. PubMed ID: 9272248
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.
    Agostini O, Bonacchi G, Coppini G, Toja E, Triolo A, Manzini S, Pieraccini G, Moneti G.
    Drug Metab Dispos; 1994 Jul; 22(2):259-68. PubMed ID: 7516853
    [Abstract] [Full Text] [Related]

  • 9. Physico-chemical properties of muroctasin.
    Moroi R, Yamazaki K, Hirota T, Watanabe S, Kataoka K, Ichinose M.
    Arzneimittelforschung; 1988 Jul; 38(7A):953-9. PubMed ID: 3190802
    [Abstract] [Full Text] [Related]

  • 10. Physico-chemical properties and stabilities of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212).
    Shimizu T, Osumi T, Niimi K, Nakagawa K.
    Arzneimittelforschung; 1984 Jul; 34(3A):334-41. PubMed ID: 6540087
    [Abstract] [Full Text] [Related]

  • 11. Physico-chemical properties and stability of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H- dibenz[2,3:6,7]oxepino[4,5-c]pyrrolidine maleate.
    Funke CW, Hindriks H, Sam AP.
    Arzneimittelforschung; 1990 May; 40(5):536-9. PubMed ID: 1974430
    [Abstract] [Full Text] [Related]

  • 12. Physico-chemical and analytical studies on plafibride.
    Torres A, Ristol P, Ribalta JM.
    Arzneimittelforschung; 1981 May; 31(10a):1786-90. PubMed ID: 7198455
    [Abstract] [Full Text] [Related]

  • 13. Radiopaque contrast media. XXXV - Physical properties of iopronic acid, a new oral cholecystographic agent.
    Felder E, Pitre D, Grandi M.
    Farmaco Sci; 1976 Jun; 31(6):426-37. PubMed ID: 1278362
    [Abstract] [Full Text] [Related]

  • 14. Identification of human urinary metabolites of isbufylline by high-performance liquid chromatography/thermospray mass spectrometry.
    Triolo A, Agostini O, Bonelli F.
    Biol Mass Spectrom; 1994 Feb; 23(2):91-6. PubMed ID: 7510130
    [Abstract] [Full Text] [Related]

  • 15. Analytical and chemical profile of pidotimod.
    Crimella T, Orlandi R, Bocchiola G, Anders U, Stradi R.
    Arzneimittelforschung; 1994 Dec; 44(12A):1405-10. PubMed ID: 7857332
    [Abstract] [Full Text] [Related]

  • 16. Structural characterization of terflavoxate.
    Leonardi A, Cappelletti R, Nardi D, Giordano F.
    Arzneimittelforschung; 1993 Mar; 43(3):356-62. PubMed ID: 8489568
    [Abstract] [Full Text] [Related]

  • 17. Preparation and properties of ryodipine, an effective antihypertensive agent.
    Kastron VV, Dubur GJ, Shatz VD, Yagupolsky LM.
    Arzneimittelforschung; 1985 Mar; 35(4):668-72. PubMed ID: 4015732
    [Abstract] [Full Text] [Related]

  • 18. Analytical-physical profile of the novel macrolide antibiotic flurithromycin ethylsuccinate.
    Colombo N, Depaoli A, Gobetti M, Saorin MG.
    Arzneimittelforschung; 1994 Jul; 44(7):850-5. PubMed ID: 7945521
    [Abstract] [Full Text] [Related]

  • 19. 2,6-cis-diphenylhexamethylcyclotetrasiloxane: physico-chemical properties and analytical methods.
    Spielvogel DE, Hanneman LF.
    Acta Pharmacol Toxicol (Copenh); 1975 Jul; 36(Suppl 3):25-32. PubMed ID: 1080331
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous determination of isbufylline and its major metabolites in rabbit blood and urine by reversed-phase high-performance liquid chromatography.
    Celardo A, Dell'Elba G, Frassanito R, Benfenati E, Bonati M.
    J Chromatogr; 1991 Aug 23; 568(2):407-18. PubMed ID: 1723732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.